A Phase I, Open-Label, Multicenter, Dose-escalation Study of the Oral Selective FGFR Inhibitor Debio 1347 in Patients with Advanced Solid Tumors Harb... - PubMed - NCBI https://t.co/0KhJyaEi3s
7,116 followers
5,829 followers
RT @CCR_AACR: Clinical Trial in the May issue: A Phase I, Open-Label, Multicenter, Dose-escalation Study of the Oral Selective FGFR Inhibit…
14,205 followers
RT @CCR_AACR: Clinical Trial in the May issue: A Phase I, Open-Label, Multicenter, Dose-escalation Study of the Oral Selective FGFR Inhibit…
76 followers